TNFSF13B and idiopathic pulmonary fibrosis: Duncan SR et al. have reported that the proportion of CXCL13 and B-lymphocyte stimulating factor (BLyS) are significantly increased in lungs and peripheral blood of patients with IPF and that CXCL13 acts as a prognostic biomarker of IPF [3, 13].